Circulating Soluble Vascular Cell Adhesion Molecule−1 and Vascular Endothelial Growth Factor in Patients with Laryngeal Squamous Cell Cancer

@inproceedings{Masalski2007CirculatingSV,
  title={Circulating Soluble Vascular Cell Adhesion Molecule−1 and Vascular Endothelial Growth Factor in Patients with Laryngeal Squamous Cell Cancer},
  author={Marcin Masalski and Beata Nadolska and Tomasz Kręcicki and Ocena stężenia},
  year={2007}
}
Background. Tumor growth and subsequent metastatic spread of cancer cells are multistep processes accompanied by changes in the expressions of many growth factors and vascular adhesion molecules. Objectives. Investigation whether serum levels of soluble vascular cell adhesion molecule−1 (sVCAM−1) and vascu− lar endothelial growth factor (VEGF) are related to clinicopathological variables of laryngeal squamous cell cancer (LSCC) patients. Material and Methods. The serum concentrations of sVCAM−1… CONTINUE READING

References

Publications referenced by this paper.
SHOWING 1-10 OF 20 REFERENCES

H−Y: Association of VCAM−1 overexpression with oncogen− esis, tumor angiogenesis and metastasis of gastric carcinoma

  • Ding Y−B, Chen G−Y, Xia J−G, Zang X−W, Yang
  • World J Gastroenterol
  • 2003
2 Excerpts

LY: Blood platelets and serum VEGF in cancer patients

  • PB Vermeulen, P Salven, I Benay, G Gasparini, Dirix
  • Br J Cancer Lett ,
  • 1999
1 Excerpt

Clinical significance of plasma Vascular Endothelial Growth Factor in gastrointestinal cancer

  • I Ohydo, T Doi, H Mendo, H Hosokawa, Y Nishikawa, M Tanimizu
  • Eur J Cancer
  • 1998
1 Excerpt

Similar Papers

Loading similar papers…